Fulgent Genetics, Inc. — Director's Dealing 2019

Aug 5, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Fulgent Genetics, Inc. (FLGT)
CIK: 0001674930
Period of Report: 2019-08-01

Reporting Person: Marsh Linda (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-08-01	Stock Option (Right to Buy)	$7.56	A	20000	Acquired	2029-08-01	Common Stock (20000)	Direct

Footnotes

F1: The shares subject to the option vest over a period of four years, with 1/4th of such shares vesting 12 months after August 1, 2019, and 1/16th of the remaining shares vesting at the end of every three-month period over the remaining 36 months, subject to Ms. Marsh's continued service for the Predecessor or the Issuer on each vesting date.